APOE4 Exacerbates Alzheimer‐Like Pathologies and Cognitive Deficits Induced by Blood‐Derived Aβ in a Mouse Model
Aging Cell · 2025
DOI: 10.1111/acel.70205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Zhong-Yuan Yu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing…. Hauptthemen laut MEDLINE: Apolipoprotein E4, Alzheimer Disease, Amyloid beta-Peptides, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program Project of China, Chongqing Municipal Science and Health Joint Research Project, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Apolipoprotein E4 (APOE4) is a significant risk for both familial Alzheimer's disease (AD) and sporadic AD with elusive mechanisms. Previous studies mainly focused on the role of APOE4 in familial AD, with less attention to sporadic AD. Our previous study demonstrated that blood cell‐derived amyloid‐β (Aβ) can enter the brain and induce AD‐like pathologies, providing a novel animal model to study sporadic AD to a certain extent. The impacts of APOE4 on Alzheimer‐like pathologies and cognitive deficits induced by blood‐derived Aβ remain unknown. In the present study, we found that APOE4 prompted the entry of blood Aβ into the brain. APOE4 recipient mice showed impaired integrity of the blood–brain barrier and higher Aβ levels in the brain after transplantation of bone marrow cells from APP/PS1•APOE4 mice. In addition, we observed that the APOE4 recipient mice displayed aggravated tau hyperphosphorylation, neuronal degeneration, neuroinflammation, and behavioral deficits at the age of 12 months. Our study demonstrates that APOE4 is capable of facilitating the entry of blood‐derived Aβ into the brain and enhancing the AD‐like pathologies triggered by blood‐derived Aβ. Our findings provide a possible way by which APOE4 elevates the risk of sporadic AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- Institute of Brain and Intelligence, Army Medical University (Third Military Medical University), Chongqing, China.
- Chongqing Key Laboratory of Ageing and Brain Diseases, Chongqing, China.
ORCID-Profile: Yan-Jiang Wang
Förderung
- National Key R&D Program Project of China
- Chongqing Municipal Science and Health Joint Research Project
- National Natural Science Foundation of China
Zitieren
APA
Yu, Z. Y., Liu, X. Y., Li, Q. Y., Tuo, J. M., Tan, Q., Liu, Z. H., Yuan, Z. Y., Zeng, R., Zhao, Y., Li, J. H., Bai, Y. D., Zeng, G. H., Chen, D. W., Bu, X. L., Jin, W. S., & Wang, Y. J. (2025). APOE4 Exacerbates Alzheimer‐Like Pathologies and Cognitive Deficits Induced by Blood‐Derived Aβ in a Mouse Model. Aging Cell. https://doi.org/10.1111/acel.70205
Vancouver
Yu ZY, Liu XY, Li QY, Tuo JM, Tan Q, Liu ZH, et al. APOE4 Exacerbates Alzheimer‐Like Pathologies and Cognitive Deficits Induced by Blood‐Derived Aβ in a Mouse Model. Aging Cell. 2025. doi:10.1111/acel.70205
BibTeX
@article{Yu2025,
author = {Yu, Zhong-Yuan and Liu, Xiao-Yu and Li, Qiong-Yan and Tuo, Jin-Mei and Tan, Qi and Liu, Zhi-Hao and Yuan, Zi-Yu and Zeng, Ru and Zhao, Yang and Li, Jiang-Hui and Bai, Yu-Di and Zeng, Gui-Hua and Chen, Dong-Wan and Bu, Xian-Le and Jin, Wang-Sheng and Wang, Yan-Jiang},
title = {APOE4 Exacerbates Alzheimer‐Like Pathologies and Cognitive Deficits Induced by Blood‐Derived Aβ in a Mouse Model},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70205}
}
EUVIMED